RSS feed

Publications (original articles or review articles) published in 2023 from OUS - The Lipid Clinic

22 publications found

Bjørnøy Urke E, Igland J, Mundal LJ, Holven KB, Retterstøl K, Svendsen K (2023)
Individuals with familial hypercholesterolemia have excess risk of eating disorders: a prospectively matched cohort study
Eur J Prev Cardiol, 30 (4), e13-e15
DOI 10.1093/eurjpc/zwac291, PubMed 36508605

de Sousa ARS, Ottestad I, Gjevestad GO, Holven KB, Ulven SM, Christensen JJ (2023)
Associations between PBMC whole genome transcriptome, muscle strength, muscle mass, and physical performance in healthy home-dwelling older women
Geroscience, 45 (6), 3175-3186
DOI 10.1007/s11357-023-00819-0, PubMed 37204640

Holven KB, Roeters van Lennep J (2023)
Sex differences in lipids: A life course approach
Atherosclerosis, 384, 117270
DOI 10.1016/j.atherosclerosis.2023.117270, PubMed 37730457

Johansen AK, Bogsrud MP, Christensen JJ, Rundblad A, Narverud I, Ulven S, Langslet G, Retterstøl K, Holven KB (2023)
Young women with familial hypercholesterolemia have higher LDL-cholesterol burden than men: Novel data using repeated measurements during 12-years follow-up
Atheroscler Plus, 51, 28-34
DOI 10.1016/j.athplu.2023.01.001, PubMed 36911286

Karasik A, Lanzinger S, Chia-Hui Tan E, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Ha KH, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K, Nyström T, Niskanen L, Linnemann Jensen M, Hoti F, Klement R, Déruaz-Luyet A, Kyaw MH, Koeneman L, Vistisen D, Carstensen B, Halvorsen S, Langslet G et al. (2023)
Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Diabetes Metab, 49 (2), 101418
DOI 10.1016/j.diabet.2022.101418, PubMed 36608816

Klevmoen M, Mulder JWCM, Roeters van Lennep JE, Holven KB (2023)
Sex Differences in Familial Hypercholesterolemia
Curr Atheroscler Rep, 25 (11), 861-868
DOI 10.1007/s11883-023-01155-6, PubMed 37815650

Macpherson ME, Skarpengland T, Hov JR, Ranheim T, Vestad B, Dahl TB, Fraz MSA, Michelsen AE, Holven KB, Fevang B, Berge RK, Aukrust P, Halvorsen B, Jørgensen SF (2023)
Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency
J Clin Immunol, 43 (6), 1229-1240
DOI 10.1007/s10875-023-01475-x, PubMed 36995502

Rodríguez-Borjabad C, Narveud I, Christensen JJ, Ibarretxe D, Andreychuk N, Girona J, Torvik K, Folkedal G, Bogsrud MP, Retterstøl K, Plana N, Masana L, Holven KB (2023)
Association between Nordic and Mediterranean diets with lipoprotein phenotype assessed by ¹HNMR in children with familial hypercholesterolemia
Atherosclerosis, 373, 38-45
DOI 10.1016/j.atherosclerosis.2023.04.009, PubMed 37137225

Roeters van Lennep JE, Tokgözoğlu LS, Badimon L, Dumanski SM, Gulati M, Hess CN, Holven KB, Kavousi M, Kayıkçıoğlu M, Lutgens E, Michos ED, Prescott E, Stock JK, Tybjaerg-Hansen A, Wermer MJH, Benn M (2023)
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society
Eur Heart J, 44 (39), 4157-4173
DOI 10.1093/eurheartj/ehad472, PubMed 37611089

Rootwelt-Norberg C, Skjølsvik ET, Chivulescu M, Bogsrud MP, Ribe MP, Aabel EW, Beitnes JO, Brekke PH, Håland TF, Hasselberg NE, Lie ØH, Haugaa KH (2023)
Disease progression rate is a strong predictor of ventricular arrhythmias in patients with cardiac laminopathies: a primary prevention cohort study
Europace, 25 (2), 634-642
DOI 10.1093/europace/euac192, PubMed 36352512

Rundblad A, Christensen JJ, Hustad KS, Bastani NE, Ottestad I, Holven KB, Ulven SM (2023)
Associations between dietary intake and glucose tolerance in clinical and metabolomics-based metabotypes
Genes Nutr, 18 (1), 3
DOI 10.1186/s12263-023-00721-6, PubMed 36899329

Rundblad A, Sandoval V, Holven KB, Ordovás JM, Ulven SM (2023)
Omega-3 fatty acids and individual variability in plasma triglyceride response: A mini-review
Redox Biol, 63, 102730
DOI 10.1016/j.redox.2023.102730, PubMed 37150150

Schreuder MM, Hamkour S, Siegers KE, Holven KB, Johansen AK, van de Ree MA, Imholz B, Boersma E, Louters L, Bogsrud MP, Retterstøl K, Visseren FLJ, Roeters van Lennep JE, Koopal C (2023)
LDL cholesterol targets rarely achieved in familial hypercholesterolemia patients: A sex and gender-specific analysis
Atherosclerosis, 384, 117117
DOI 10.1016/j.atherosclerosis.2023.03.022, PubMed 37080805

Skytte HN, Christensen JJ, Gunnes N, Holven KB, Lekva T, Henriksen T, Michelsen TM, Roland MCP (2023)
Metabolic profiling of pregnancies complicated by preeclampsia: A longitudinal study
Acta Obstet Gynecol Scand, 102 (3), 334-343
DOI 10.1111/aogs.14505, PubMed 36647289

Strøm TB, Asprusten E, Laerdahl JK, Øygard I, Hussain MM, Bogsrud MP, Leren TP (2023)
Missense mutation Q384K in the APOB gene affecting the large lipid transfer module of apoB reduces the secretion of apoB-100 in the liver without reducing the secretion of apoB-48 in the intestine
J Clin Lipidol (in press)
DOI 10.1016/j.jacl.2023.08.009, PubMed 37718180

Strøm TB, Tveita AA, Bogsrud MP, Leren TP (2023)
Molecular genetic testing and measurement of levels of GPIHBP1 autoantibodies in patients with severe hypertriglyceridemia: The importance of identifying the underlying cause of hypertriglyceridemia
J Clin Lipidol (in press)
DOI 10.1016/j.jacl.2023.11.002, PubMed 37981531

Troensegaard H, Khoury J, Westerberg AC, Tonstad S, Roeters van Lennep J, Veierød MB, Iversen PO, Holven KB, Retterstøl K (2023)
Protocol for a 20-year follow-up after a randomized controlled trial of a Mediterranean diet in pregnancy: maternal and offspring risk factors for cardiovascular disease
Front Pediatr, 11, 1256815
DOI 10.3389/fped.2023.1256815, PubMed 37920793

Van Parys A, Sæle J, Puaschitz NG, Anfinsen ÅM, Karlsson T, Olsen T, Haugsgjerd TR, Vinknes KJ, Holven KB, Dierkes J, Nygård OK, Lysne V (2023)
The association between dairy intake and risk of cardiovascular disease and mortality in patients with stable angina pectoris
Eur J Prev Cardiol, 30 (3), 219-229
DOI 10.1093/eurjpc/zwac217, PubMed 36134600

Vinknes KJ, Olsen T, Zaré HK, Bastani NE, Stolt E, Dahl AF, Cox RD, Refsum H, Retterstøl K, Åsberg A, Elshorbagy A (2023)
Cysteine-lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose-finding study
Diabetes Obes Metab, 25 (11), 3161-3170
DOI 10.1111/dom.15210, PubMed 37435697

Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan EC, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Núñez J, Ha KH, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani SF et al. (2023)
Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
Cardiovasc Diabetol, 22 (1), 233
DOI 10.1186/s12933-023-01963-9, PubMed 37653496

Øhman EA, Fossli M, Ottestad I, Holven KB, Ulven SM, Løland BF, Brekke HK (2023)
Dietary treatment postpartum in women with obesity reduces weight and prevents weight gain: a randomised controlled trial
BMC Pregnancy Childbirth, 23 (1), 695
DOI 10.1186/s12884-023-05976-w, PubMed 37752466

Øyri LKL, Christensen JJ, Sebert S, Thoresen M, Michelsen TM, Ulven SM, Brekke HK, Retterstøl K, Brantsæter AL, Magnus P, Bogsrud MP, Holven KB (2023)
Maternal prenatal cholesterol levels predict offspring weight trajectories during childhood in the Norwegian Mother, Father and Child Cohort Study
BMC Med, 21 (1), 43
DOI 10.1186/s12916-023-02742-9, PubMed 36747215